Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study
-
- Timna Agur
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Naomi Ben-Dor
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Shira Goldman
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Shelly Lichtenberg
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Michal Herman-Edelstein
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Dafna Yahav
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
-
- Benaya Rozen-Zvi
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
-
- Boris Zingerman
- Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
収録刊行物
-
- Nephrology Dialysis Transplantation
-
Nephrology Dialysis Transplantation 36 (7), 1347-1349, 2021-04-11
Oxford University Press (OUP)